Author:
Vlachaki Efthimia,Tselios Konstantinos,Charalambidou Stella,Ioannidou Elizabeth,Klonizakis Ioannis
Publisher
Springer Science and Business Media LLC
Reference7 articles.
1. Sawada K, Hirokawa M, Fujishima N, et al. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica. 2007;92:1021–8. doi:
10.3324/haematol.11192
.
2. Dessypris EN, Lipton JM. Red cell aplasia. In: Greer JP, Foerster J, Lukens JN, et al., editors. Wintrobe’s clinical hematology. 11th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 1421–7.
3. Srinivas U, Mahapatra M, Saxena R, et al. Thirty nine cases of pure red cell aplasia: a single center experience from India. Hematology. 2007;12:245–8. doi:
10.1080/10245330701255056
.
4. Ramadan KM, Anderson JA, McMullin MF, et al. Idiopathic pure red cell aplasia: first report on CD8 positive lymphocytosis in bone marrow biopsy sections. J Clin Pathol. 2005;58(10):1118–20. doi:
10.1136/jcp.2004.020875
.
5. Suzuki T, Kumagai T, Kitano A, et al. Pure red cell aplasia successfully treated with rituximab in a patient with relapsed diffuse large B-cell lymphoma. Rinsho Ketsueki. 2007;48:67–70.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献